Skip to content

CANNABIS SUISSE CORP.: 10-Q filed 2025-01-13

What CANNABIS SUISSE CORP. reported in its quarterly report filed 2025-01-13 (fiscal Q2 2025): 35 published measures, 108 facts as tagged in accession 0001393905-25-000017.

This filing

Form
10-Q (quarterly report)
Filed
2025-01-13
Fiscal period
fiscal Q2 2025
Accession
0001393905-25-000017 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CANNABIS SUISSE CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-11-30751,847USD
At 2024-05-31896,623USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-11-302,627,701USD
At 2024-05-312,242,453USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-11-304,100USD
At 2024-05-3128,562USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-09-01 to 2024-11-305,062USD91
2024-06-01 to 2024-11-30-530,024USD183
2023-09-01 to 2023-11-30-54,797USD91
2023-06-01 to 2023-11-30-119,554USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-06-01 to 2024-11-30-24,462USD183
2023-06-01 to 2023-11-30-21,755USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-09-01 to 2024-11-307,500USD91
2024-06-01 to 2024-11-3015,000USD183
2023-09-01 to 2023-11-307,500USD91
2023-06-01 to 2023-11-3015,000USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-06-01 to 2024-11-300USD183
2023-06-01 to 2023-11-3027,000USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-06-01 to 2024-11-300USD183
2023-06-01 to 2023-11-300USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-11-30-3,130,928USD
At 2024-05-31-2,600,904USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-09-01 to 2024-11-3070,680,938shares91
2024-06-01 to 2024-11-3070,680,938shares183
2023-09-01 to 2023-11-3045,837,356shares91
2023-06-01 to 2023-11-3045,041,823shares183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-09-01 to 2024-11-30195,823,835shares91
2024-06-01 to 2024-11-3070,680,938shares183
2023-09-01 to 2023-11-3045,837,356shares91
2023-06-01 to 2023-11-3045,041,823shares183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-09-01 to 2024-11-300USD/shares91
2024-06-01 to 2024-11-30-0.01USD/shares183
2023-09-01 to 2023-11-300USD/shares91
2023-06-01 to 2023-11-300USD/shares183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-09-01 to 2024-11-300USD/shares91
2024-06-01 to 2024-11-30-0.01USD/shares183
2023-09-01 to 2023-11-300USD/shares91
2023-06-01 to 2023-11-300USD/shares183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-09-01 to 2024-11-300USD91
2024-06-01 to 2024-11-300USD183
2023-09-01 to 2023-11-300USD91
2023-06-01 to 2023-11-300USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-11-3022,490USD
At 2024-05-3124,612USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-06-01 to 2024-11-300USD183
2023-06-01 to 2023-11-3020,000USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-09-01 to 2024-11-30-92,309USD91
2024-06-01 to 2024-11-30-167,148USD183
2023-09-01 to 2023-11-30-50,702USD91
2023-06-01 to 2023-11-30-111,319USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-11-30135,063USD
At 2024-05-31196,453USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2024-09-01 to 2024-11-3016,120USD91
2024-06-01 to 2024-11-3030,969USD183
2023-09-01 to 2023-11-304,095USD91
2023-06-01 to 2023-11-308,235USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-11-30278,647USD
At 2024-05-31381,000USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-11-3026,550USD
At 2024-05-314,304USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-09-01 to 2024-11-3092,453USD91
2024-06-01 to 2024-11-30167,436USD183
2023-09-01 to 2023-11-3051,328USD91
2023-06-01 to 2023-11-30112,570USD183

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-09-01 to 2024-11-30144USD91
2024-06-01 to 2024-11-30288USD183
2023-09-01 to 2023-11-30626USD91
2023-06-01 to 2023-11-301,251USD183

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-11-304,100USD
At 2024-05-3128,562USD
At 2023-11-305,444USD
At 2023-05-31199USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-11-301,179,393USD
At 2024-05-311,179,393USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-11-30-1,875,854USD
At 2024-08-31-1,880,916USD
At 2024-05-31-1,345,830USD
At 2023-11-30-409,001USD
At 2023-08-31-384,204USD
At 2023-05-31-329,447USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-11-30594,294USD
At 2024-05-31675,558USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-11-30101,669USD
At 2024-05-31166,093USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-11-3010,610USD
At 2024-05-318,488USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-09-01 to 2024-11-305,062USD91
2024-06-01 to 2024-11-30-530,024USD183
2023-09-01 to 2023-11-30-54,797USD91
2023-06-01 to 2023-11-30-119,554USD183

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-09-01 to 2024-11-305,062USD91
2024-06-01 to 2024-08-31-535,086USD92
2023-09-01 to 2023-11-30-54,797USD91
2023-06-01 to 2023-08-31-64,757USD92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-09-01 to 2024-11-3055,198USD91
2024-06-01 to 2024-11-30110,041USD183
2023-09-01 to 2023-11-3028,267USD91
2023-06-01 to 2023-11-3056,448USD183

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-09-01 to 2024-11-301,061USD91
2024-06-01 to 2024-11-302,122USD183
2023-09-01 to 2023-11-301,061USD91
2023-06-01 to 2023-11-302,122USD183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-09-01 to 2024-11-3097,371USD91
2024-06-01 to 2024-11-30-362,876USD183
2023-09-01 to 2023-11-30-4,095USD91
2023-06-01 to 2023-11-30-8,235USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-06-01 to 2024-11-300USD183
2023-06-01 to 2023-11-3020,000USD183

Inspect the source

Entity
CANNABIS SUISSE CORP. / CIK 0001680132
Captured
2026-09-21T17:24:53.137Z
SEC response SHA-256
c24d9f7acc4eb8aea0bf19a6348735a6c6aa452887bf9f68f95fdc7968f6d5f9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001680132.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))